FibroBiologics Secures European Patent for Fibroblast Delivery of Cancer Treatments

Bitget2026/11/05 13:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

FibroBiologics received a European patent covering fibroblasts engineered to deliver oncolytic viruses to tumors.
Patent protection extends to the modified cells for cancer treatment alongside existing therapies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fibrobiologics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611050830PR_NEWS_USPR_____DA89312) on November 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

FibroBiologics Secures European Patent for Fibroblast Delivery of Cancer Treatments

You may also like

Crypto prices